![](/img/cover-not-exists.png)
Recombinant tissue plasminogen activator (rtPA) and stroke unit for acute ischaemic stroke in developing countries, are they cost-effective?
Rahil Alsadat Shahtaheri, Afshin Borhani Haghighi, Anahid Safari, Salvador Cruz-FloresVolume:
7
Year:
2012
Language:
english
DOI:
10.1111/j.1747-4949.2012.00892.x
File:
PDF, 41 KB
english, 2012